With close of research reactors, landscape is shifting for Europe’s world-leading neutron science community
17 DEC 2019
Three neutron science research reactors in Europe have ceased operations in 2019. The League of advanced European Neutron Sources, LENS, and the European Neutron Scattering Association, ENSA, warn of a “neutron gap” that could impact scientific research across multiple fields in physics, materials science, chemistry, biology, medical science and engineering. Together, LENS and ENSA are working on a new vision to maintain Europe’s leading position in neutron science.
Neutrons are unique and have a half-century legacy of socio-economic impact in Europe. Fifty percent of neutron science publications globally are attributed to European researchers from academia and industry, working at European neutron sources. Neutrons record, for example, the interior dynamics of lithium-ion batteries, reveal obscured minutiae from ancient artefacts or clarify the mechanisms of antibiotic resistance in bacteria. Cancerous tumours are treated with radiopharmaceuticals produced with neutrons. Neutrons are also critical for industrial and engineering researchers developing more efficient fuel cells for electric vehicles or testing stress and strain during the manufacturing of carbon-free steel.
Three European research reactors central to the decades of success in the European neutron landscape were shut down this year: Orphée, used by the Laboratoire Léon Brillouin (LLB) near Paris, BER II at the Helmholtz-Zentrum Berlin, and JEEP II operated by the Institute for Energy Technology outside Oslo,. Each of these reactors operated as a national facility primarily serving researchers in France, Germany and Norway, but also hosted scores of international researchers through trans-national access programmes. Each was closed for reasons unique to its national research agenda.
A new European neutron source, the European Spallation Source (ESS), based on spallation rather than reactor technology, is currently under construction in southern Sweden. It will not be available to scientific users until 2023, however, and will take several years to ramp up to full capacity. Meanwhile, the 2019 reactor closures leave Germany’s FRM II in Garching and the 50-year-old ILL in Grenoble, France, as the last major neutron research reactors in their respective countries.
Christiane Alba-Simionesco, former director of LLB and chair of ENSA, says:
“The European neutron user community is in a paradoxical, even schizophrenic situation. We must prepare the current and next generation of users to make the best use of what will be the most powerful source in the world, ESS, while on balance we are facing considerably reduced access to instruments in Europe. This could result in a neutron gap. It’s a simple fact that a reduction in the number of facilities, the number of instruments and the number of operating days at European facilities naturally limits the size of the user community and its scientific contribution to societal challenges. Meanwhile, neutron user associations around the world have made it clear that there is increasing interest in the use of neutron scattering throughout academia and industry.“
Helmut Schober, LENS chair and director of Europe’s flagship neutron facility, the Institut Laue-Langevin (ILL) says:
“European neutron science owes its outstanding performance over the last 50 years largely to the close-knit network of facilities available to scientists. The three reactors closed in 2019 were all vital pillars of this network, in particular BER II in Berlin and Orphée in Paris, which both ran extensive international user programmes. Fortunately, significant steps have already been taken to prepare for these closures. ESS is well on its way, while the remaining major European sources have invested heavily into upgrading their capacities and capabilities. In addition, LLB will maintain its neutron activities by engaging in strong collaborations with other facilities and the future ESS. Provided we can maintain the proper level of support, Europe can expect to retain its world-leading position.”
The European Neutron Scattering Association (ENSA) has a membership of 7,000 registered scientists in 21 countries, accounting for half of the world’s scientific production from neutron scattering. The European countries represented by ENSA include Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Romania, Russia, Slovakia, Spain, Sweden, Switzerland and the United Kingdom. More information at neutrons-ensa.eu.
- Neutrons for organic solar energy technologies (ISIS Neutron and Muon Source, UK)
- Neutron experiments reveal proteins which can inhibit amyloid plaque formation (Insitut Laue-Langevin, France)
- Toxic and aggressive, but widely used (Heinz Maier-Leibnitz Zentrum, Germany)
- Neutrons for building a car (Budapest Neutron Centre, Hungary)
- Future Science: What will we see at ESS? (European Spallation Source, Sweden)
- Coincidence helps expand cornerstone of physics (Forschungszentrum Jülich, Germany)
- Successful demonstration of neutron scattering as a characterization method for battery materials – silicon nanoparticles (Institute for Energy Technology, Norway)
- Membrane interaction of off-pathway prion oligomers and lipid-induced onpathway intermediates during prion conversion: A clue for neurotoxicity (Laboratoire Léon Brillouin, France)
- A hand like no other (Paul Scherrer Institut, Switzerland)
Recent News & Events
- From 15 - 19 February 2021, over 80 participants attended the online LENS Machine Learning School. The school, which was targeted towards neutron and muon facilities staff, offered a gateway for beginner and intermediate coders to get into machine learning, providing an overview of modern and traditional machine learning techniques alongside neutron or muon based applications.
- Register for the RI.Logistica conference today and be part of an unparalleled international forum that will impact how research infrastructures deal with logistics in the future.
- LENS Webinar #10 on ‘Drug development and drug delivery systems ‘ with Andrey Kovalevski (ORNL) & Marianna Yanez Arteta (AstraZeneca Mölndal)This webinar will focus on how neutrons can provide crucial information to study the structure-dynamics-function relationships in macromolecular drug targets and to design successful drug delivery systems.